Skip to search formSkip to main contentSkip to account menu

Phentermine

Known as: alpha,alpha-Dimethylphenethylamine, Phentermine [Chemical/Ingredient], Phenterminum 
A natural monoamine alkaloid derivative and a sympathomimetic stimulant with appetite suppressant property. Phentermine, which was part of the Fen… 
National Institutes of Health

Related topics

Related topics

38 relations

Narrower (11)

2-methyl-2-nitro-1-phenylpropane4-iodophentermineAdipex-PDuromine
24 HR Phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia]Appetite Suppression [PE]ArteriosclerosisChild

Broader (5)

Adrenergic AgentsAmphetamineAppetite DepressantsCentral Nervous System Stimulants

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Management of obesity
Review
2014
Review
2014
Long-term drug treatment for obesity: a systematic and clinical review.
IMPORTANCE Thirty-six percent of US adults are obese, and many cannot lose sufficient weight to improve health with lifestyle… 
Highly Cited
2013
Highly Cited
2013
Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults
A 28‐week, randomized, controlled trial compared the combination of phentermine and topiramate extended‐release (PHEN/TPM ER… 
Highly Cited
2011
Highly Cited
2011
Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
A 56‐week randomized controlled trial was conducted to evaluate safety and efficacy of a controlled‐release combination of… 
Highly Cited
2011
Highly Cited
2011
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled…
Highly Cited
2011
Highly Cited
2011
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension…
Background: Obesity is a serious chronic disease. Controlled-release phentermine/topiramate (PHEN/TPM CR), as an adjunct to… 
Review
2008
Review
2008
Health services research
DL-FENFLURAMINE AND PHENTERMINE USE IN OBESE ADOLESCENTS: THE RELATIONSHIP BETWEEN AGE AND TREATMENT SUCCESS. SL Emerson_ CM… 
Highly Cited
2001
Highly Cited
2001
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing… 
Highly Cited
2000
Highly Cited
2000
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.
Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has reduced penetrance and that has been… 
Highly Cited
1997
Highly Cited
1997
Valvular heart disease associated with fenfluramine-phentermine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)